“ Pills could replace Covid jabs with British biotech breakthrough
Sussex-based IosBio has found a way to turn injected vaccines into tablets and signed a deal with California's ImmunityBio
Putting Covid vaccines into pills could soon move from dream to reality after a Sussex-based biotech signed an agreement with a US pharmaceutical company to test the technology in clinical trials.
Burgess Hill-based IosBio has found a way to turn injected vaccines into orally administered tablets. The technology is now being used by ImmunityBio, a Californian company developing a vaccine against Covid after signing a licensing agreement with iosBio.
Clinical trials in monkeys have shown the oral vaccine made using iosBio technology to be highly effective, while the jab version is already in phase two/three trials.
The oral vaccine will begin clinical trials on Americans this month and ImmunityBio is applying for regulatory approval to run trials in the UK.“
Pills could replace Covid jabs with British biotech breakthrough
Sussex-based IosBio has found a way to turn injected vaccines into tablets and signed a deal with California's ImmunityBio
Putting Covid vaccines into pills could soon move from dream to reality after a Sussex-based biotech signed an agreement with a US pharmaceutical company to test the technology in clinical trials.
Burgess Hill-based IosBio has found a way to turn injected vaccines into orally administered tablets. The technology is now being used by ImmunityBio, a Californian company developing a vaccine against Covid after signing a licensing agreement with iosBio.
Clinical trials in monkeys have shown the oral vaccine made using iosBio technology to be highly effective, while the jab version is already in phase two/three trials.
The oral vaccine will begin clinical trials on Americans this month and ImmunityBio is applying for regulatory approval to run trials in the UK.“
Pills could replace Covid jabs with British biotech breakthrough
Comment